A Double Blind, Randomized, Placebo Controlled Clinical Study To Evaluate The Efficacy And Safety Of Tfn34 Tablets For Individuals With Subclinical And Clinical Hypothyroidism. (2022). Journal of Pharmaceutical Negative Results, 8599-8614. https://doi.org/10.47750/pnr.2022.13.S09.1010